Organisation paid for research Program year 2025 Source: CMS Open Payments

Ascension Seton

Neither a doctor nor a teaching hospital

Research payments

$1,550,965

418 payments

Through program year 2025, Ascension Seton is reported as receiving $1,550,965 in research payments, across 418 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$20,835	5
2024	Research	$1,118,863	156
2023	Research	$185,278	27
2022	Research	$117,717	43
2021	Research	$40,596	62
2020	Research	$47,639	124
2019	Research	$20,038	1

Breakdown

Who paid Research payments · program years 2019–2025

Janssen Research & Development, LLC $1,274,055 178 payments
Alexion Pharmaceuticals, Inc. $108,950 1 payment
Biotronik Inc. $38,395 204 payments
Bayer HealthCare Pharmaceuticals Inc. $35,732 22 payments
Stryker Corporation $22,875 2 payments
Boehringer Ingelheim Pharmaceuticals, Inc. $20,038 1 payment
Sanofi US Services Inc. $16,335 4 payments
Surmodics, Inc. $14,990 1 payment
InspireMD Ltd $8,129 1 payment
Krystal Biotech Inc $4,500 1 payment

Studies the money was for Research payments · program years 2019–2025

70033093Afl3002 $779,459 73 payments
70033093Str3001 $337,060 47 payments
70033093Acs3003 $157,536 58 payments
A Phase 4 Randomized Clinical Trial of Andexanet Alfa, Andexanet Alfa for Injection, in Acute Intracranial Hemorrhage in Patients Receiving An Oral Factor Xa Inhibitor $108,950 1 payment
Bioflow-VII $38,395 204 payments
A multicenter randomized double-blind parallel-group placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction = 40% (LVEF = 40%) $31,936 12 payments
Clinical and Radiographic Outcomes of Bio4 Bone Matrix in Patients Undergoing 1- Or 2-Level Anterior Cervical Discectomy and Fusion Surgery $22,875 2 payments
GLORIA AF Registry Phase II III Core $20,038 1 payment
A Prospective Observational Study to Assess the Long-term Safety and Immunogenicity of Olipudase Alfa Therapy During Routine Clinical Care in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency $16,335 4 payments
Pounce Thrombectomy System Retrospective Registry (PROWL) $14,990 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.